Biopharma’s R&D engine and the importance of looking east
One of the main topics of conversation at the beginning of 2025 is how pharma companies should build their pipelines and the rising role that China is playing. A widely-cited report from Stifel showed that 30% of large pharma’s licensing deals now involve a Chinese biotech. This shows the growing interest in partnering in the […]
Spotlight on India: A booming part of the global ecosystem
In a series exploring trends across the APAC region, Norstella’s subject matter experts from key biopharma hubs delve into last year’s standout developments and share their outlook for 2025. Andrew Warmington, Manufacturing Editor at Citeline, spoke to Anju Ghangurde, Executive Editor, APAC, Citeline, and Vibha Ravi, Senior Editor, APAC, Citeline. How would you describe the […]
Complex cohort identification fuels real-time HCP targeting
Learn how one manufacturer used integrated claims, lab, EMR and coverage data to identify newly diagnosed, early-stage cancer patients for just-in-time HCP targeting.
The greatest opportunities to enhance drug development in 2025
The pharma industry continues to persevere through talent shortages, supply chain disruptions, data challenges, and many more obstacles that are making it increasingly difficult to get life-saving treatments to patients. However, the thirst for innovation and drive to make a difference for patients around the world is what keeps this sector going. As we start […]